8-K - REVIVA PHARMACEUTICALS HOLDINGS, INC. - 7.01 / 8.01 / 9.01
站内整理正文
Form 8-K - Current report: SEC Accession No. 0001437749-26-012303
Filing Date: 2026-04-15
Accepted: 2026-04-15 08:05:13
Documents: 13
Period of Report: 2026-04-15
Items: Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK : 0001742927 (see all company filings) EIN. : 000000000 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-38634 | Film No.: 26862571 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | FORM 8-K | rvph20260414_8k.htm iXBRL | 8-K
2 | EXHIBIT 99.1 | ex_945819.htm | EX-99.1
3 | XBRL TAXONOMY EXTENSION SCHEMA | rvph-20260415.xsd | EX-101.SCH
4 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | rvph-20260415_def.xml | EX-101.DEF